A risk assessment tool for resumption of research activities during the COVID-19 pandemic for field trials in low resource settings is a research paper published in BMC Medical Research Methodology (2021). On theSindex it has a DataRank of 0.521. It has been cited 11 times, with 3 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.373
From this paper's citation signal
Citation Network Contribution
0.148
From 3 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 3 citers.
U.S. National Institutes of Health
Grant: 1UM1HL134590
Bill and Melinda Gates Foundation
Grant: OPP1131279
National Heart, Lung, and Blood Institute
Grant: 1F32HL143909-01
National Heart, Lung, and Blood Institute
Grant: K12HL137942
Fogarty International Center
Grant: D43TW009340
NHLBI NIH HHS
Grant: F32 HL143909
NHLBI NIH HHS
Grant: UM1 HL134590
FWCI
0.62
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of A risk assessment tool for resumption of research activities during the COVID-19 pandemic for field trials in low resource settings
Additional file 1 of A risk assessment tool for resumption of research activities during the COVID-19 pandemic for field trials in low resource settings
A risk assessment tool for resumption of research activities during the COVID-19 pandemic for field trials in low resource settings
A risk assessment tool for resumption of research activities during the COVID-19 pandemic for field trials in low resource settings